Sales at AstraZeneca soared 60 per cent in the first quarter, boosted by demand for its Covid-19 vaccine and the rare diseases medicines it acquired as part of its acquisition of Alexion. The UK drugmaker announced sales of $11.4bn, above the analyst consensus of $10.9bn, bolstered by $1.1bn coming from its Covid vaccine and $1.7bn
0 Comments
The ghostly, vibrato-laden sustains, shrieks and honking low-note groans that Albert Ayler conjured from his tenor saxophone sounded outrageous when they surfaced in the early 1960s. And, as this compelling four-CD box-set audibly demonstrates, they still sound outrageous today. The collection presents two complete concerts from the Fondation Maeght art museum in the South of
0 Comments
The writer is a managing director at BlackRock For the private equity and venture capital firms of Bangalore, 2021 was a fine year. Inflows surged to record levels and a flurry of technology firms achieved “unicorn” status, with capital raisings that valued them at $1bn or higher. As central bank largesse supported markets around the
0 Comments
Good morning. I’m not sure what to make of the negative first-quarter GDP number, which was a disappointment, but included a huge shift in the trade balance, which may be noise. But we are seeing slower growth elsewhere, so in any case the report was not wildly anomalous. The employment cost index, out this morning,
0 Comments
Alice Murray has three complaints about her neighbourhood in Scotland: lamp posts, dog poo and politicians. Standing outside her pebble-dashed house in Springburn, a northern suburb of Glasgow, the 85-year-old bemoaned the poor infrastructure, particularly the rusting street lights. Murray, who voted Labour all her life until 2017 when she backed the Scottish National party
0 Comments